Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma

被引:189
作者
Hoffman, JA
Giraudo, E
Singh, M
Zhang, LL
Inoue, M
Porkka, K
Hanahan, D
Ruoslahti, E
机构
[1] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Diabet & Comprehens Canc Ctr, San Francisco, CA 94143 USA
[3] Burnham Inst, Canc Res Ctr, La Jolla, CA 92037 USA
[4] Burnham Inst, Program Mol Pathol, La Jolla, CA 92037 USA
[5] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92037 USA
关键词
D O I
10.1016/S1535-6108(03)00273-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Phage display was used to identify homing peptides for blood vessels in a mouse model of HPV16-induced epidermal carcinogenesis. One peptide, CSRPRRSEC, recognized the neovasculature in dysplastic skin but not in carcinomas. Two other peptides, with the sequences CGKRK and CDTRL, preferentially homed to neovasculature in tumors and, to a lesser extent, premalignant dysplasias. The peptides did not home to vessels in normal skin, other normal organs, or the stages in pancreatic islet carcinogenesis in another mouse model. The CGKRK peptide may recognize heparan sulfates in tumor vessels. The dysplasia-homing peptide is identical to a loop in kallikrein-9 and may bind a kallikrein inhibitor or substrate. Thus, characteristics of the angiogenic vasculature distinguish premalignant and malignant stages of skin tumorigenesis.
引用
收藏
页码:383 / 391
页数:9
相关论文
共 47 条
[1]   Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].
Arap, W ;
Pasqualini, R ;
Ruoslahti, E .
SCIENCE, 1998, 279 (5349) :377-380
[2]   PROGRESSIVE SQUAMOUS EPITHELIAL NEOPLASIA IN K14-HUMAN PAPILLOMAVIRUS TYPE-16 TRANSGENIC MICE [J].
ARBEIT, JM ;
MUNGER, K ;
HOWLEY, PM ;
HANAHAN, D .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4358-4368
[3]  
Arbeit JM, 1996, ONCOGENE, V13, P1847
[4]   Effects of angiogenesis inhibitors on multistage carcinogenesis in mice [J].
Bergers, G ;
Javaherian, K ;
Lo, KM ;
Folkman, J ;
Hanahan, D .
SCIENCE, 1999, 284 (5415) :808-812
[5]   Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors [J].
Bergers, G ;
Song, S ;
Meyer-Morse, N ;
Bergsland, E ;
Hanahan, D .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09) :1287-1295
[6]   DIFLUOROMETHYLORNITHINE ENHANCES INHIBITION OF MELANOMA CELL-GROWTH IN SOFT AGAR BY DEXAMETHASONE, CLONE A INTERFERON AND RETINOIC ACID [J].
BREGMAN, MD ;
MEYSKENS, FL .
INTERNATIONAL JOURNAL OF CANCER, 1986, 37 (01) :101-107
[7]  
Burg MA, 1999, CANCER RES, V59, P2869
[8]   Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 [J].
Carmeliet, P ;
Ng, YS ;
Nuyens, D ;
Theilmeier, G ;
Brusselmans, K ;
Cornelissen, I ;
Ehler, E ;
Kakkar, VV ;
Stalmans, I ;
Mattot, V ;
Perriard, JC ;
Dewerchin, M ;
Flameng, W ;
Nagy, A ;
Lupu, F ;
Moons, L ;
Collen, D ;
D'Amore, PA ;
Shima, DT .
NATURE MEDICINE, 1999, 5 (05) :495-502
[9]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[10]   Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood [J].
Chang, YS ;
di Tomaso, E ;
McDonald, DM ;
Jones, R ;
Jain, RK ;
Munn, LL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (26) :14608-14613